Antibodies against human respiratory syncytial virus (RSV) and methods of use
US9365638B2 · kind B2 · utility
4Cited by
91References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 2013 |
| Grant date | Jun 14, 2016 |
| Priority date | — |
| Expiry date | Mar 10, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are antibodies or antigen-binding fragments thereof that immunospecifically bind to the fusion (F) protein of Respiratory Syncytial Virus (RSV). Also provided are methods for of prevention, treatment and diagnosis of viral infection and/or the treatment of one more symptoms of RSV-mediated disease. Methods of generating antibodies that immunospecifically bind RSV F protein also are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.